TKT and neoplasm: The feasibility of targeting EGFR for tumor imaging has been experimentally demonstrated using 18F or 11C-labeled EGFR-TK inhibitors [14–20]; however, these labeled compounds were also observed to produce high radioactivity in the blood and peripheral tissues.